Hill Emily Luisa
SEC CIK 1778279 · EDGAR
BoughtSold
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Transactions 23
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 18:42 | 2026-08-17 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $14.28 | -9,256 | 215.9K | -4% | -$132.2K | |
| 2026-08-12 17:06 | 2026-08-10 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $12.97 | -11.4K | 225.1K | -5% | -$148.5K | |
| 2026-05-20 16:15 | 2026-05-18 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $5.08 | -7,812 | 236.6K | -3% | -$39.7K | |
| D | 2026-04-07 21:08 | 2026-04-01 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +50.0K | 244.4K | +26% | $0 |
| 2025-12-19 | 2025-12-19 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +60.0K | 194.4K | +45% | $0 | |
| 2025-08-19 | 2025-08-15 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $5.37 | -9,154 | 134.4K | -6% | -$49.2K | |
| 2025-05-22 | 2025-05-20 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $8.05 | -2,535 | 143.5K | -2% | -$20.4K | |
| D | 2025-04-03 | 2025-04-01 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +45.0K | 146.1K | +45% | $0 |
| 2024-08-19 | 2024-08-16 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | S - Sale | $10.18 | -8,938 | 101.1K | -8% | -$91.0K | |
| D | 2024-04-03 | 2024-04-01 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +26.7K | 110.0K | +32% | $0 |
| D | 2023-09-20 | 2023-09-18 | REPL | Replimune Group, Inc. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +83.3K | 83.3K | New | $0 |
| 2023-03-29 | 2023-03-27 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $45.00 | -7,363 | 38.9K | -16% | -$331.3K | |
| 2023-02-02 | 2023-01-31 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $45.63 | -575 | 46.3K | -1% | -$26.2K | |
| 2023-01-26 | 2023-01-24 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $47.45 | -223 | 46.9K | -0.5% | -$10.6K | |
| M | 2023-01-12 | 2023-01-10+ | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $43.58 | -915 | 47.1K | -2% | -$39.9K |
| 2023-01-11 | 2023-01-09 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $41.66 | -758 | 48.0K | -2% | -$31.6K | |
| D | 2023-01-09 | 2023-01-05 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +19.5K | 48.8K | +67% | $0 |
| 2022-04-01 | 2022-03-31 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $37.78 | -7,910 | 29.3K | -21% | -$298.8K | |
| 2022-02-03 | 2022-02-01 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $40.00 | -553 | 37.2K | -1% | -$22.1K | |
| 2022-01-27 | 2022-01-25 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $39.31 | -211 | 37.7K | -0.6% | -$8,294 | |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | A - Grant | $0.00 | +15.6K | 37.9K | +70% | $0 |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $38.53 | -800 | 22.3K | -3% | -$30.8K |
| 2022-01-06 | 2022-01-04 | PTCT | PTC THERAPEUTICS, INC. | Hill Emily Luisa | CFO | S - Sale | $41.16 | -173 | 23.1K | -0.7% | -$7,121 |
Purchase Sale Sale after option exercise All abbreviations